B.R. Eaton, R. Schwarz, R. Vatner, B. Yeh, L. Claude, D.J. Indelicato, N. Laack, Osteosarcoma. Pediatr. Blood Cancer 68(Suppl 2), e28352 (2021)

Article  PubMed  Google Scholar 

P.S. Meltzer, L.J. Helman, New Horizons in the treatment of osteosarcoma. N. Engl. J. Med. 385, 2066–2076 (2021)

Article  CAS  PubMed  Google Scholar 

Y. Jiang, J. Wang, M. Sun, D. Zuo, H. Wang, J. Shen, W. Jiang, H. Mu, X. Ma, F. Yin, J. Lin, C. Wang, S. Yu, L. Jiang, G. Lv, F. Liu, L. Xue, K. Tian, G. Wang, Z. Zhou, Y. Lv, Z. Wang, T. Zhang, J. Xu, L. Yang, K. Zhao, W. Sun, Y. Tang, Z. Cai, S. Wang, Y. Hua, Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment. Nat. Commun. 13, 7207 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

S.M. Sanderson, X. Gao, Z. Dai, J.W. Locasale, methionine metabolism in health and cancer: a nexus of diet and precision medicine. Nat. Rev. Cancer 19, 625–637 (2019)

Article  CAS  PubMed  Google Scholar 

H. Mu, C. Liu, Q. Zhang, H. Meng, S. Yu, K. Zeng, J. Han, X. Jin, S. Shi, P. Yu, T. Li, J. Xu, Y. Hua, Magnetic-driven hydrogel microrobots selectively enhance synthetic lethality in MTAP-deleted osteosarcoma. Front. Bioeng. Biotechnol. 10, 911455 (2022)

Article  PubMed  PubMed Central  Google Scholar 

H. Mu, D. Zuo, J. Chen, Z. Liu, Z. Wang, L. Yang, Q. Shi, Y. Hua, Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis. Cancer Biol. Med. 19, 1397–1409 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J.M. García-Castellano, A. Villanueva, J.H. Healey, R. Sowers, C. Cordon-Cardo, A. Huvos, J.R. Bertino, P. Meyers, R. Gorlick, Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma. Clin. Cancer Res. 8, 782–787 (2002)

PubMed  Google Scholar 

R.A. Casero Jr., T. Murray Stewart, A.E. Pegg, Polyamine metabolism and cancer: treatments, challenges and opportunities. Nat. Rev. Cancer 18, 681–695 (2018)

Article  CAS  PubMed  PubMed Central  Google Scholar 

C.E. Holbert, M.T. Cullen, R.A. Casero Jr., T.M. Stewart, Polyamines in cancer: integrating organismal metabolism and antitumour immunity. Nat. Rev. Cancer 22, 467–480 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

C. Quinn, M.C. Rico, C. Merali, S. Merali, Dysregulation of S-adenosylmethionine metabolism in nonalcoholic steatohepatitis leads to polyamine flux and oxidative stress. Int. J. Mol. Sci. 23 (2022)

M. Kitada, Y. Ogura, I. Monno, J. Xu, D. Koya, Effect of methionine restriction on aging: its relationship to oxidative stress. Biomedicines 9 (2021)

S. Vrijsen, M. Houdou, A. Cascalho, J. Eggermont, P. Vangheluwe, Polyamines in Parkinson’s disease: balancing between neurotoxicity and neuroprotection. Annu. Rev. Biochem. 92, 435–464 (2023)

Article  CAS  PubMed  Google Scholar 

B. Kang, X. Wang, X. An, C. Ji, W. Ling, Y. Qi, S. Li, D. Jiang, Polyamines in ovarian aging and disease. Int. J. Mol. Sci. 24 (2023)

S.P. Narayanan, M. Rojas, J. Suwanpradid, H.A. Toque, R.W. Caldwell, R.B. Caldwell, Arginase in retinopathy. Prog Retin Eye Res. 36, 260–280 (2013)

Article  CAS  PubMed  Google Scholar 

S. Nakanishi, J.L. Cleveland, Polyamine homeostasis in development and disease. Med. Sci. (Basel) 9 (2021)

I. Novita Sari, T. Setiawan, K. Seock Kim, Y. Toni Wijaya, K. Won Cho, Young Kwon, metabolism and function of polyamines in cancer progression. Cancer Lett. 519, 91–104 (2021)

Article  CAS  PubMed  Google Scholar 

A.V. Tangella, A.S. Gajre, P.C. Chirumamilla, P.V. Rathhan, Difluoromethylornithine (DFMO) and neuroblastoma: a review. Cureus 15, e37680 (2023)

Y. Zhang, T.T. Zhang, L. Gao, Y.N. Tan, Y.T. Li, X.Y. Tan, T.X. Huang, H.H. Li, F. Bai, C. Zou, X.H. Pei, B.B. Tan, L. Fu, Downregulation of MTAP promotes tumor growth and metastasis by regulating ODC activity in breast cancer. Int. J. Biol. Sci. 18, 3034–3047 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.B. Ayoola, L.A. Shack, J.H. Lee, J. Lim, H. Eoh, E. Swiatlo, O.t. Phanstiel, B. Nanduri, Difluoromethylornithine (DFMO) and AMXT 1501 inhibit capsule biosynthesis in pneumococci. Sci. Rep. 12, 11804 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

O. El Naggar, B. Doyle, K. Mariner, S.K. Gilmour, Difluoromethylornithine (DFMO) enhances the cytotoxicity of PARP inhibition in ovarian cancer cells. Med. Sci. (Basel), 10 (2022)

Y. Jiang, G. Wang, H. Mu, X. Ma, Z. Wang, Y. Lv, T. Zhang, J. Xu, J. Wang, Y. Li, J. Han, M. Yang, Z. Wang, K. Zeng, X. Jin, S. Xue, M. Yin, W. Sun, Y. Hua, Z. Cai, Bromodomain inhibition attenuates the progression and sensitizes the chemosensitivity of osteosarcoma by repressing GP130/STAT3 signaling. Front. Oncol. 11, 642134 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Yafei, M. Haoran, J. Wenyan, X. Linghang, T. Kai, W. Gangyang, W. Zhuoying, H. Jing, Y. Mengkai, T. Yujie, H. Yingqi, C. Zhengdong, Personalized medicine modality based on patient-derived xenografts from a malignant transformed GCTB harboring H3F3A G34W mutation. J. Orthop. Translat. 29, 106–112 (2021)

Article  PubMed  PubMed Central  Google Scholar 

H. Mu, Y. Jiang, L. Xue, Y. Hua, J. Lin, Z. Cai, H3.3 K36M mutation as a clinical diagnosis method of suspected chondroblastoma cases. Orthop. Surg. 13, 616–622 (2021)

Article  PubMed  PubMed Central  Google Scholar 

A. Dobin, C.A. Davis, F. Schlesinger, J. Drenkow, C. Zaleski, S. Jha, P. Batut, M. Chaisson, T.R. Gingeras, STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013)

Article  CAS  PubMed  Google Scholar 

Y. Liao, G.K. Smyth, W. Shi, featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014)

Article  CAS  PubMed  Google Scholar 

M.I. Love, W. Huber, S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014)

Article  PubMed  PubMed Central  Google Scholar 

G. Yu, L.G. Wang, Y. Han, Q.Y. He, clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16, 284–287 (2012)

Article  CAS  PubMed  PubMed Central  Google Scholar 

A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, J.P. Mesirov, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U S A 102, 15545–15550 (2005)

Article  CAS  PubMed  PubMed Central  Google Scholar 

A. Liberzon, A. Subramanian, R. Pinchback, H. Thorvaldsdóttir, P. Tamayo, J.P. Mesirov, Molecular signatures database (MSigDB) 3.0, Bioinformatics 27, 1739–1740 (2011)

A. Liberzon, C. Birger, H. Thorvaldsdóttir, M. Ghandi, J.P. Mesirov, P. Tamayo, The Molecular signatures database (MSigDB) hallmark gene set collection. Cell. Syst. 1, 417–425 (2015)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J.J. Morrow, A. Mendoza, A. Koyen, M.M. Lizardo, L. Ren, T.J. Waybright, R.J. Hansen, D.L. Gustafson, M. Zhou, T.M. Fan, P.C. Scacheri, C. Khanna, mTOR inhibition mitigates enhanced mRNA translation associated with the metastatic phenotype of osteosarcoma cells in vivo. Clin. Cancer Res. 22, 6129–6141 (2016)

Article  CAS  PubMed  PubMed Central  Google Scholar 

T. Zhang, C. Bauer, A.C. Newman, A.H. Uribe, D. Athineos, K. Blyth, O.D.K. Maddocks, Polyamine pathway activity promotes cysteine essentiality in cancer cells. Nat. Metab. 2, 1062–1076 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

C. Bray, C. Balcells, I.A. McNeish, H.C. Keun, The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality. Front. Oncol. 13, 1264785 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Yang, Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway. Br. J. Cancer 130, 513–516 (2024)

Article